Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. - Wikidata - awgldk - TriplyDB

Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle.

Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle.

http://www.wikidata.org/entity/Q36255817

about

Sox15 is required for skeletal muscle regeneration The cell adhesion molecule M-cadherin is not essential for muscle development and regeneration IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma Muscle regeneration and myogenic differentiation defects in mice lacking TIS7 microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7 Myogenic specification of side population cells in skeletal muscle Netrins and neogenin promote myotube formation Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells Pax7 is necessary and sufficient for the myogenic specification of CD45+:Sca1+ stem cells from injured muscle Skeletal muscle stem cells Effects of Nandrolone in the Counteraction of Skeletal Muscle Atrophy in a Mouse Model of Muscle Disuse: Molecular Biology and Functional Evaluation Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis Overexpression of Akt1 enhances adipogenesis and leads to lipoma formation in zebrafish Transcriptomic and network component analysis of glycerol kinase in skeletal muscle using a mouse model of glycerol kinase deficiency Stress-induced C/EBP homology protein (CHOP) represses MyoD transcription to delay myoblast differentiation Megf10 regulates the progression of the satellite cell myogenic program Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation Down-regulation of MyoD by calpain 3 promotes generation of reserve cells in C2C12 myoblasts Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha Regeneration of transgenic skeletal muscles with altered timing of expression of the basic helix-loop-helix muscle regulatory factor MRF4 Acetylation is important for MyoD function in adult mice An initial blueprint for myogenic differentiation Xin, an actin binding protein, is expressed within muscle satellite cells and newly regenerated skeletal muscle fibers Separating myoblast differentiation from muscle cell fusion using IGF-I and the p38 MAP kinase inhibitor SB202190.Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex.MyoD- and nerve-dependent maintenance of MyoD expression in mature muscle fibres acts through the DRR/PRR element.The atypical Rac activator Dock180 (Dock1) regulates myoblast fusion in vivo A home away from home: challenges and opportunities in engineering in vitro muscle satellite cell niches p38-{gamma}-dependent gene silencing restricts entry into the myogenic differentiation program.Activation of Cdc6 by MyoD is associated with the expansion of quiescent myogenic satellite cells.Transforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiation.Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy Loss of MyoD Promotes Fate Transdifferentiation of Myoblasts Into Brown Adipocytes.Satellite cells and the muscle stem cell niche Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle.The role of stem cells in skeletal and cardiac muscle repair.In vitro indeterminate teleost myogenesis appears to be dependent on Pax3 MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3 Mouse Pop1 is required for muscle regeneration in adult skeletal muscle.Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardium

P2860

Q24304057-7E25EA2C-A29B-4F69-805B-8250B0533C85 Q24537537-AD857796-3E69-44B1-A6A7-9DA6C0662BC7 Q24601302-C18E9870-6489-4BD5-A9A9-7A0FB47CF3CA Q24602530-A2833DAC-9789-4ECE-B31D-757B3DF18D0B Q24615529-0EF76D83-3B3B-449E-93E7-FB018D054B8A Q24672806-8E7E3B85-8380-4B65-9EC9-2B4339FE8C1A Q24676178-01FA9266-BE85-4F4C-A563-3382703F9640 Q24676703-32062DBF-7D02-4FF9-8C34-F0EA5559B0DF Q24796796-0F1EFDD8-583A-4ED8-BF7A-005261E0EB48 Q24801042-8E92188E-22BC-42A8-A8DD-EED6DF148204 Q27304606-09CBCFBC-6873-4A66-86FA-8EC7B38DB35F Q28294844-79B965F3-204C-49B4-8916-9DACD8256FF4 Q28483822-C7EFAD5C-3CE9-479B-8C1E-E143B76E0C5B Q28507112-D23F7F97-EEC2-44EB-BB7D-E67267390B9B Q28510649-653C016F-E9D1-46AE-A8A8-0C1291C02966 Q28511899-635D46A7-3614-4224-AD3A-5FE0F6676BFA Q28511959-06B30B78-7611-4E50-8E74-252B95218A2C Q28512068-B992922B-451D-424B-BCB6-E1A20AA8A16C Q28513388-477A92FC-E2AD-4DB3-B746-D59D27920D23 Q28573663-F73B62E9-CAF4-4B1A-81DC-2AEFF4A51998 Q28582566-F87B6DAD-01C4-4D8D-9A24-3706E1DBBFD3 Q28588060-C8E84777-2503-4871-9202-FCC8670924C5 Q28589167-7C2BCDA7-9583-428C-981E-87724371F7BD Q30666846-5FB07A17-BCA8-4958-9C15-E1B7B3BB9693 Q33309162-C042E8F1-935B-4244-AFDF-35B35423D8B8 Q33316197-E0527580-8D42-462F-8A27-2DDE59E621DC Q33372285-6694AB25-7183-46AB-B542-93382D1537A3 Q33571203-6C5F23B4-0A47-4B27-8E70-50202724C316 Q33589771-F53623F8-A928-4F8B-A973-356E7F45E80F Q33616461-FBF45277-F4FD-493B-882A-8EC07B560EE4 Q33673668-A1382B7E-0BA9-45F1-828D-633F1DA43855 Q33702390-B79B7728-FA03-4279-84EE-C859C07A7860 Q33809481-5C933B3F-F268-49BE-959A-D8259BEC58D6 Q33816665-F8BE7767-E94D-4DC0-8F26-5329A27895C3 Q33924659-63AFE342-1748-4EB8-AB2D-4DA67226CFBC Q34124836-CF31D8D7-17D3-4B43-9A46-6CC9F01FE5F3 Q34138165-91779A78-A458-4B63-BD1F-610591EA9A69 Q34218839-FF08EF70-0DC2-4C62-BD3C-8773A58A96CE Q34302313-C00B56D4-1A41-4DD3-B30F-1985D7071821 Q34358919-2DD08FD5-1E83-4C09-AD6C-10D70E6EA6BB

P2860

Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle.

http://www.wikidata.org/entity/Q36255817

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Reduced differentiation potent ...... ed from adult skeletal muscle.

@ast

Reduced differentiation potent ...... ed from adult skeletal muscle.

@en

type

label

Reduced differentiation potent ...... ed from adult skeletal muscle.

@ast

Reduced differentiation potent ...... ed from adult skeletal muscle.

@en

prefLabel

Reduced differentiation potent ...... ed from adult skeletal muscle.

@ast

Reduced differentiation potent ...... ed from adult skeletal muscle.

@en

P1433

Q36255817-BE21A8AD-717B-4D10-9C89-35900C21B965

P1476

Q36255817-BCBF73C0-5339-4C72-87D3-E39F3952C7F0

P2093

Q36255817-06497370-A4B0-449C-84FF-1B0C7B2BA211

Q36255817-3162D010-A3FF-4F42-9D07-2B341FFC24A5

Q36255817-3F18EDDD-11C6-4F9F-A0ED-FF06DBF1B150

Q36255817-C61A95D0-2E1D-4FE6-B4F3-8D66F2C217C1

P2860

Q36255817-00DCCB49-00C9-4308-A059-17010793A95D

Q36255817-09580784-C69F-4A6F-8F1E-8D20FACBA906

Q36255817-0AF02CF5-88DA-421B-A873-38BB98BF321E

Q36255817-17167E41-ABA2-40A2-B8D7-416BF2A1DE6E

Q36255817-1FA703C6-4A15-4FBF-8939-D907676010A0

Q36255817-20EBF57A-05ED-40A3-9BF3-4A8ABADEB837

Q36255817-23DDB382-292D-4B63-B8A4-D3AD73C560AF

Q36255817-265D8F0E-DCBF-4731-A82B-A04FD47A5F2C

Q36255817-2C9F04B3-FD73-45B9-95FC-B0A2835840ED

Q36255817-2E03AF0D-C3B3-4066-AEF3-82B2B5CF3FBA

P304

Q36255817-AE0D5BAB-A9FA-4C58-97CF-578D9D48AB91

P31

Q36255817-0C77FA69-5440-445B-93B3-960208068F50

P356

Q36255817-D2AA44B1-BCB5-4E8A-871D-81E2CECBBFDA

P407

Q36255817-68927350-76E6-472F-8920-4413ECF9AFD5

P433

Q36255817-AE7F295F-EDF7-4AA7-9780-98F66E5669F4

P478

Q36255817-C1312202-3007-4C4F-BCD3-25FCC3A2B44E

P50

Q36255817-F780031C-1F99-492F-A588-13DC2F0C2E79

P577

Q36255817-CA98AB6C-789C-4AEC-B4A6-707D74E9C3D8

P5875

Q36255817-DD922B03-1ECA-40D5-840C-879905BA4B22

P698

Q36255817-69A6BF1E-64E1-4D2C-B17D-87FB29C8CBCF

P932

Q36255817-27F558DE-A7D1-4B78-BAFE-3174B6511A65

P356

P1433

Journal of Cell Biology

P1476

Reduced differentiation potent ...... ed from adult skeletal muscle.

@en

P2093

A Girgis-Gabardo

http://www.w3.org/2001/XMLSchema#string

L A Sabourin

http://www.w3.org/2001/XMLSchema#string

M A Rudnicki

http://www.w3.org/2001/XMLSchema#string

P Seale

http://www.w3.org/2001/XMLSchema#string

P2860

The myoD gene family: nodal point during specification of the muscle cell lineage

New functional activities for the p21 family of CDK inhibitors

Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

WAF1, a potential mediator of p53 tumor suppression

The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo

Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies

MyoD or Myf-5 is required for the formation of skeletal muscle

Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways

Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome

P304

631-643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.144.4.631

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

144

http://www.w3.org/2001/XMLSchema#string

P50

Atsushi Asakura

P577

1999-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274468853

http://www.w3.org/2001/XMLSchema#string

P698

10037786

http://www.w3.org/2001/XMLSchema#string

P932

2132931

http://www.w3.org/2001/XMLSchema#string